Rani Therapeutics Holdings, Inc. ( RANI) - Key Metrics
RANI Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.04 | -$0.05 | -$0.05 |
| 2026Q1 | $0.01 | -$0.04 | -$0.04 | -$0.04 |
| 2025Q4 | $0.01 | -$0.07 | $0 | $0 |
| 2025Q3 | $0 | -$0.15 | -$0.14 | -$0.14 |
| 2025Q2 | $0 | -$0.18 | -$0.16 | -$0.16 |
RANI Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.75 |
| 2026Q1 | 0% | -4.70 |
| 2025Q4 | 0% | -4.82 |
| 2025Q3 | 0% | -1.04 |
| 2025Q2 | 0% | -0.71 |
RANI
Price: $0.88
52 week price:
Earnings Per Share: -0.13 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 116.0 million